Cytek Biosciences Inc Stock Ownership - Who owns Cytek Biosciences?

Insider buying vs selling

Have Cytek Biosciences Inc insiders been buying or selling?
Patrik JeanmonodChief Financial Officer2023-11-243,000$6.94
Ming YanChief Technology Officer2023-11-2020,000$6.03
Wenbin JiangPresident and CEO2023-11-183,965$5.98
Valerie BarnettGeneral Counsel2023-11-181,434$5.98
Valerie BarnettGeneral Counsel2023-11-18786$5.98
Ming YanChief Technology Officer2023-11-18772$5.98
Paul Christopher WilliamsChief Operating Officer2023-11-181,569$5.98
Ming YanChief Technology Officer2023-11-182,431$5.98
Patrik JeanmonodChief Financial Officer2023-11-18683$5.98
Patrik JeanmonodChief Financial Officer2023-11-181,434$5.98

1 of 9

CTKB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTKB insiders and whales buy or sell their stock.

CTKB Shareholders

What type of owners hold Cytek Biosciences Inc stock?
Blackrock Inc12.37%16,770,673$122.76MInstitution
Brown Capital Management LLC10.00%13,560,480$99.26MInstitution
Ra Capital Management LP9.87%13,381,054$97.95MInsider
Vanguard Group Inc8.17%11,079,421$81.10MInstitution
Wenbin Jiang5.87%7,954,695$58.23MInsider
Ming Yan5.73%7,762,103$56.82MInsider
Ra Capital Management LP5.02%6,809,404$49.84MInstitution
Hhlr Advisors Ltd4.91%6,657,030$48.73MInstitution
State Street Corp2.79%3,777,543$27.65MInstitution
Geode Capital Management LLC1.74%2,354,452$17.23MInstitution

1 of 3

CTKB vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTKB57.09%22.03%Net SellingNet Selling
AHCO44.47%55.53%Net SellingNet Selling
AVNS93.12%2.41%Net SellingNet Selling
FNA13.86%86.14%Net SellingNet Selling
QTRX64.31%35.69%Net BuyingNet Selling

Cytek Biosciences Stock Ownership FAQ

Who owns Cytek Biosciences?

Cytek Biosciences (NASDAQ: CTKB) is owned by 57.09% institutional shareholders, 22.03% Cytek Biosciences insiders, and 20.88% retail investors. Ra Capital Management LP is the largest individual Cytek Biosciences shareholder, owning 13.38M shares representing 9.87% of the company. Ra Capital Management LP's Cytek Biosciences shares are currently valued at $102.50M.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.